News for November 2015

News Archive

NICE Recommends BioMarin’s Vimizim®? (elosulfase alfa) for the Treatment of Morquio A Syndrome in England NICE Recommends BioMarin’s Vimizim®? (elosulfase alfa) for the Treatment of Morquio A Syndrome in England

Recommendation Provides Patient Access to Treatment for Ultra-Rare Condition with Reimbursement

Cobra Biologics Appointed by University of Sheffield to Advance Novel Fusion Protein Technology into Phase 1 Clinical Trials Cobra Biologics Appointed by University of Sheffield to Advance Novel Fusion Protein Technology into Phase 1 Clinical Trials

Manufacturing service will scale production of growth hormone developed using ‘ProFuse’ Technology

Narcolepsy treatment recommended for approval Narcolepsy treatment recommended for approval

Wakix to target excessive daytime sleepiness and cataplexy

MSD in the UK launches new antibiotic to treat complicated intra-abdominal and urinary tract infections, and acute pyelonephritis MSD in the UK launches new antibiotic to treat complicated intra-abdominal and urinary tract infections, and acute pyelonephritis

MSD (Merck & Co., Inc., Kenilworth, NJ, USA) today announces the availability of Zerbaxa®? (ceftolozane/tazobactam) in the UK, a new intravenous antibiotic for the treatment of complicated intra-abdominal infections (cIAI), acute pyelonephritis and complicated urinary tract infections (cUTI) in hospital settings. Ceftolozane /tazobactam offers an alternative to carbapenems, currently a standard treatment for ESBL-producing organisms which have been linked to the emergence of carbapenem-resistant bacteria contributing to global antimicrobial resistance (AMR)

Scripps Florida Scientists Unveil Critical Mechanism of Memory Formation Scripps Florida Scientists Unveil Critical Mechanism of Memory Formation

In a new study that could have implications for future drug discovery efforts for a number of neurodegenerative diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that the interaction between a pair of brain proteins has a substantial and previously unrecognized effect on memory formation.

TSRI Scientists Find Surprising Trait in Anti-HIV Antibodies TSRI Scientists Find Surprising Trait in Anti-HIV Antibodies

Advances in Search of an AIDS VaccineScientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.

TSRI-Led Team Finds Long-Sought Protein Sensor for the 'Sixth Sense'—Proprioception TSRI-Led Team Finds Long-Sought Protein Sensor for the 'Sixth Sense'—Proprioception

Can you touch a finger to the tip of your nose with your eyes closed? Most of us can, thanks to a sense called proprioception, which tells us where our body parts are relative to each other and our environment. Not surprisingly, this sense is essential for normal movement and balance—walking, for instance.

St. Jude and Scripps Research Institute Scientists Help Launch Human Dark Proteome Initiative St. Jude and Scripps Research Institute Scientists Help Launch Human Dark Proteome Initiative

Group to focus on advancing research on intrinsically disordered proteins to better understand catastrophic diseases

GSK marks 300th Anniversary GSK marks 300th Anniversary

Seven times great nephew of founder continues heritage of discovery and innovation

Experts gather to discuss evidence for the use of music interventions in neurological disorders in older people Experts gather to discuss evidence for the use of music interventions in neurological disorders in older people

Experts in the field of neurology, psychology, rehabilitation and music therapy will gather at the Royal Society of Medicine in London on Monday 16 November to discuss the use of music interventions in older people with conditions including stroke, dementia, brain injuries and motor disorders.

Patent Box consultation will provide greater certainty to UK businesses, says Withers & Rogers Patent Box consultation will provide greater certainty to UK businesses, says Withers & Rogers

Reassurance on the future of the UK’s Patent Box Scheme is positive news for UK companies, according to leading intellectual property firm Withers & Rogers.

The Current issue of “The view from here” discusses Industry/Academic models The Current issue of “The view from here” discusses Industry/Academic models

The topic of this month’s newsletter from Drug Discovery Today is Industry/Academic models.